AptarGroup, Inc.: Initiation Of Coverage – Will The Expansion & Refining Of Manufacturing Operations Catalyze Growth?

Aptar, a global leader in dispensing and drug delivery solutions, achieved core sales growth of 3% and an
adjusted earnings per share (EPS) of $1.37 in the second quarter of 2024. This marks a 12% increase over the
prior year’s quarter, continuing the positive momentum seen in the first half of the year. The company’s promising
results were buoyed by strong demand in its pharma proprietary drug delivery systems and broad-based margin
improvements, leading to a recently announced dividend increase of approximately 10%.